dm+d

29896003

Articles

Understanding safety risks with betamethasone soluble tablets used as mouthwash

9 July 2021Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm

Safety in Lactation: Corticosteroids

9 November 2020There is very limited information on the use of corticosteroids during breastfeeding, although they are likely to be present in milk. Avoid prolonged high dose…

Safety in Lactation: Drugs used in nasal allergy

27 October 2020Drugs used for nasal allergy have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence…

Safety in Lactation: Topical corticosteroids

23 September 2020Topical corticosteroids are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid direct contact of the…

Safety in Lactation: Drugs for oral ulceration and inflammation

21 September 2020The use of oropharyngeal anti-inflammatories/analgesics is not considered to present any risk to a breastfeeding infant. Doxycycline is considered to present negligible risk when used…
Search Articles

Medicine Compliance Aid Stability

genericAAH

AAH
generic
Tablets soluble 0.5mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablet so unsuitable for MCA
23 January 2015

BetnesolRecipharm Limited (UK)

Recipharm Limited (UK)
Betnesol
Tablets soluble 500microgram
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets so unsuitable for MCA.
1 September 2015

Lactation Safety Information

Oral / Parenteral

Oral / Parenteral
Prednisolone (oral), Hydrocortisone (parenteral)
No published evidence of safety
Used in infants >1 month
Doses up to 8mg daily unlikely to cause adverse effects in the infant
24 September 2020

Local injection

Local injection
Yes
24 September 2020

For ophthalmic use

For ophthalmic use
Yes
There are no additional risks when used in combination ophthalmic preparations containing neomycin
24 September 2020

For use in the ear

For use in the ear
Yes
There are no additional risks when used in combination aural preparations containing neomycin
24 September 2020

For intranasal use

For intranasal use
Yes
24 September 2020

Soluble tablets for orophayngeal use

Soluble tablets for orophayngeal use
Yes
24 September 2020

All esters for topical use

All esters for topical use
Yes
High potency
There are no additional risks when used in combination topical preparations containing antimicrobials or salicylic acid
24 September 2020